CAS No. :	518-34-3
Formula :	C₃₈H₄₂N₂O₆
M.W :	622.75
SMILES Code :	CN1CCC2=CC(OC)=C(O3)C=C2[C@]1([H])CC4=CC=C(OC5=C(OC)C=CC(C[C@@]6([H])C7=C3C(OC)=C(OC)C=C7CCN6C)=C5)C=C4
Synonyms :	NSC-77037; d-Tetrandrine; TTD.
MDL No. :	MFCD08689909
InChI Key :	WVTKBKWTSCPRNU-KYJUHHDHSA-N
Pubchem ID :	73078

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302
Precautionary Statements:	P280-P305+P351+P338

HepG2 cells	2 μg/mL	12 hours	To detect TET-CTM/L induced apoptosis in HepG2 cells, results showed that TET-CTM/L significantly induced apoptosis.	Int J Nanomedicine. 2024 Jan 23;19:727-742.
Huh7 cells	0, 0.5, 1, 2 or 4 µM	24 hours	Tetrandrine significantly inhibited the migration and invasion of Huh7 cells	J Exp Clin Cancer Res. 2018 Jan 15;37(1):7.
HCCLM9 cells	0, 0.5, 1, 2 or 4 µM	24 hours	Tetrandrine significantly inhibited the migration and invasion of HCCLM9 cells	J Exp Clin Cancer Res. 2018 Jan 15;37(1):7.
Hep3B cells	0, 0.5, 1, 2 or 4 µM	24 hours	Tetrandrine significantly inhibited the migration and invasion of Hep3B cells	J Exp Clin Cancer Res. 2018 Jan 15;37(1):7.
HepG2 cells	0.675-20 μg/mL	24 hours	To evaluate the cytotoxicity of TET-CTM/L against HepG2 cells, results showed that TET-CTM/L has significant anti-tumor efficacy.	Int J Nanomedicine. 2024 Jan 23;19:727-742.
Murine peritoneal macrophages	100 µM	3 hours	Tetrandrine inhibited NLRP3 inflammasome activation and reduced the release of IL-1β and IL-18.	Acta Pharmacol Sin. 2022 May;43(5):1274-1284.
Cardiac myocytes	10 µM	30 minutes	Tetrandrine significantly inhibited Ang II-induced ROS generation	Br J Pharmacol. 2010 Feb;159(4):970-81.
K562	2 µM	48 hours	Tetrandrine inhibited the proliferation of K562 cells and induced cell cycle arrest at the G0/G1 phase.	Cell Death Dis. 2018 May 1;9(5):473.
THP-1	2 µM	48 hours	Tetrandrine inhibited the proliferation of THP-1 cells and induced cell cycle arrest at the G0/G1 phase.	Cell Death Dis. 2018 May 1;9(5):473.
HL60	2 µM	48 hours	Tetrandrine inhibited the proliferation of HL60 cells and induced cell cycle arrest at the G0/G1 phase.	Cell Death Dis. 2018 May 1;9(5):473.
U937	2 µM	48 hours	Tetrandrine inhibited the proliferation of U937 cells and induced cell cycle arrest at the G0/G1 phase.	Cell Death Dis. 2018 May 1;9(5):473.
K562 cells	2 µM	48 hours	Tetrandrine induced cell cycle arrest and megakaryocyte differentiation in K562 cells via activation of autophagy.	Br J Pharmacol. 2017 Dec;174(23):4308-4328.
6133 cells	2 µM	48 hours	Tetrandrine induced cell cycle arrest and megakaryocyte differentiation in 6133 cells via activation of autophagy.	Br J Pharmacol. 2017 Dec;174(23):4308-4328.
CMK cells	2 µM	48 hours	Tetrandrine induced cell cycle arrest and megakaryocyte differentiation in CMK cells via activation of autophagy.	Br J Pharmacol. 2017 Dec;174(23):4308-4328.
HEL cells	2 µM	48 hours	Tetrandrine induced cell cycle arrest and megakaryocyte differentiation in HEL cells via activation of autophagy.	Br J Pharmacol. 2017 Dec;174(23):4308-4328.
RAW264.7 cells	0.3 µM	6 hours	Tetrandrine significantly inhibited RANKL-induced osteoclastogenesis and enhanced the ubiquitination and degradation of Syk through the AhR/c-src/c-Cbl signaling pathway.	Cell Death Dis. 2019 Jan 15;10(2):38.
BMMs	0.3 µM	6 hours	Tetrandrine significantly inhibited RANKL-induced osteoclastogenesis and enhanced the ubiquitination and degradation of Syk through the AhR/c-src/c-Cbl signaling pathway.	Cell Death Dis. 2019 Jan 15;10(2):38.
Human breast cancer cells (MDA-MB-231, MDA-MB-468, MCF-7)	0-5 µM	72 hours	Tetrandrine alone or in combination with H89 exhibited antitumor effects on various cancer cells, and the combination showed synergistic effects.	J Exp Clin Cancer Res. 2018 Jun 4;37(1):114.
Human hepatoma cells (Hep3B, Huh7)	0-5 µM	72 hours	Tetrandrine alone or in combination with H89 exhibited antitumor effects on various cancer cells, and the combination showed synergistic effects.	J Exp Clin Cancer Res. 2018 Jun 4;37(1):114.
Human renal carcinoma cells (769-P, ACHN, 786-O)	0-5 µM	72 hours	Tetrandrine alone or in combination with H89 exhibited antitumor effects on various cancer cells, and the combination showed synergistic effects.	J Exp Clin Cancer Res. 2018 Jun 4;37(1):114.
Human colon cancer cells (LOVO, HCT116)	0-5 µM	72 hours	Tetrandrine alone or in combination with H89 exhibited antitumor effects on various cancer cells, and the combination showed synergistic effects.	J Exp Clin Cancer Res. 2018 Jun 4;37(1):114.

Nude mice	HepG2 xenograft tumor model	Intraperitoneal injection	1.5 mg/kg	Once every two days for 24 days	To evaluate the in vivo anti-tumor efficacy of TET-CTM/L, results showed that TET-CTM/L significantly inhibited tumor growth.	Int J Nanomedicine. 2024 Jan 23;19:727-742.
Mice	Thy1-hTau.P301S transgenic mice	Intraperitoneal injection	2.5 mg/kg, 5 mg/kg, 10 mg/kg	Every two days for two months	To study the effect of Tetrandrine on tau aggregation and cognitive dysfunction, results showed that Tetrandrine reduced tau aggregation in a dose-dependent manner and improved memory function in mice.	J Biomed Sci. 2022 Oct 22;29(1):85
Nude mice (BALB/c)	MDA-MB-231 xenograft model	Oral and intraperitoneal injection	25 mg/kg	Every other day for 28 days	The combination of Tetrandrine and H89 significantly inhibited tumor growth in vivo, showing synergistic effects.	J Exp Clin Cancer Res. 2018 Jun 4;37(1):114.
Nude mice	Subcutaneous tumor xenograft model	Oral	25 mg/kg or 50 mg/kg	Once daily for 13 days	Tetrandrine significantly inhibited tumor growth and promoted tumor cell differentiation.	Cell Death Dis. 2018 May 1;9(5):473.
Nude mice	HCCLM9 subcutaneous tumor xenograft model	Oral	30 mg/kg	Every other day for 37 days	Tetrandrine significantly inhibited lung metastasis of HCCLM9 cells in vivo	J Exp Clin Cancer Res. 2018 Jan 15;37(1):7.
Nude mice	K562 tumor xenograft model	Oral	50 mg/kg	Once daily for 23 days	Tetrandrine significantly inhibited the growth of K562 tumors, reducing tumor volume and weight.	Br J Pharmacol. 2017 Dec;174(23):4308-4328.
C57BL/6J mice	Silicosis model	Gavage	50 mg/kg or 100 mg/kg	Once daily for 4 weeks	Tetrandrine alleviated pulmonary inflammation and fibrosis, and improved lung function in silicosis mice.	Acta Pharmacol Sin. 2022 May;43(5):1274-1284.
C57/B6 mice	Aortic banding (AB) model	Oral gavage	50 mg/kg/day	Three times a day for one week	Tetrandrine significantly attenuated AB-induced cardiac hypertrophy, reduced heart weight/body weight and lung weight/body weight ratios, and inhibited fibrosis and inflammatory response	Br J Pharmacol. 2010 Feb;159(4):970-81.

NCT04308317	Corona Virus Disease 2019,COVI... More >>D-19 Less <<	PHASE4	UNKNOWN	2021-05-01	Tetrandrine Tablets, Jinhua, Z... More >>hejiang, 321000, China Less <<
NCT05697029	COVID-19	PHASE4	WITHDRAWN	2025-12-12	Peking University Third Hospit... More >>al, Beijing, Beijing, 100191, China Less <<

{[proInfo.proName]}

CAS No.: 518-34-3

{[proInfo.proName]}

CAS No.: 518-34-3

Alternative Products

Product Details of Tetrandrine

Safety of Tetrandrine

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed